Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eu Hwa herbal medicine for Alzheimer's disease is a natural product-based therapeutic candidate currently in preclinical development by Daehwa Pharmaceutical (also referred to as Eu Hwa). The candidate is being developed under the dual classifications of herbal medicine and functional food, specifically targeting the treatment or prevention of Alzheimer's disease. As part of Daehwa Pharmaceutical's natural product pipeline, it represents an effort to leverage traditional or botanical ingredients for neurodegenerative conditions. Detailed information regarding its specific botanical composition, active chemical constituents, and molecular targets has not been publicly disclosed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Eu Hwa herbal medicine for Alzheimer's disease.